Potential value of color-coded dynamic breast-specific gamma-imaging; comparing 99mTc-(V)-DMSA, 99mTc-MIBI, and 99mTc-HDP in a mouse mammary tumor model

Applied Radiation and Isotopes

Volumn 68, Issue 12, 2010, Pages 2117-2124

  van Leeuwen, Fijs W B ^a   Buckle, Tessa ^a   Batteau, Lukas ^a   Pool, Bert ^a   Sinaasappel, Michiel ^a   Jonkers, Jos ^a   Gilhuijs, Kenneth G A ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

99mTc; Breast cancer; Breast specific gamma imaging; Small animal imaging; SPECT

Indexed keywords

99MTC; BREAST CANCER; BREAST-SPECIFIC GAMMA-IMAGING; SMALL ANIMAL IMAGING; SPECT;

ANIMALS; TUMORS;

PIXELS;

ETIDRONIC ACID TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; SUCCIMER TC 99M; TECHNESCAN DMSA; TECHNESCAN HDP; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCINTILLATION CAMERA; SCINTIMAMMOGRAPHY; TISSUE SPECIFICITY;

ANIMALS; COLOR; FEMALE; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMOGRAPHY; MICE; MICROSCOPY, CONFOCAL; ORGANOTECHNETIUM COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956435419     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2010.05.008     Document Type: Article

References (24)

1. Althuis M.D., et al. Global trends in breast cancer incidence and mortality 1973-1997. Int. J. Epidemiol. 2005, 34:405-412.
2. Brem R.F., et al. Breast-specific gamma-imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology 2008, 247:651-659.
3. Boetes C., et al. The role of MRI in invasive lobular carcinoma. Breast Cancer Res. Treat. 2004, 86:31-37.
4. Berg W.A., et al. Diagnostic accuracy of mammography, clinical examination, US, and MRI imaging in preoperative assessment of breast cancer. Radiology 2004, 233:830-849.
5. Derksen P.W.B., et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006, 10:437-449.
6. Frese K.K., Tuveson D.A. Maximizing mouse cancer models. Nat. Rev. Cancer 2007, 7:645-658.
7. Gilhuijs K.G., et al. Breast MR imaging in women at increased lifetime risk of breast cancer: clinical system for computerized assessment of breast lesions initial results. Radiology 2002, 225:907-916.
8. Helvie M.A., et al. Invasive lobular carcinoma: imaging features and clinical detection. Invest. Radiol. 1993, 28:202-207.
9. 99mTc-sestamibi and a small-field-of-view gamma-camera. J. Nucl. Med. Technol. 2009, 37:201-205.
10. Jurisson S., et al. Coordination compounds in nuclear medicine. Chem. Rev. 1993, 1137-1156.
11. Krecke K.N., Gisvold J.J. Invasive lobular carcinoma in the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am. J. Roengenol. 1993, 161:957-960.
12. Kim I.J., et al. Comparison of double phase Tc-99m MIBI and Tc-99m terosfosmin scintimammography for characterization of breast lesions: visual and quantitative analysis. Neoplasma 2008, 55:526-531.
13. Kirkup L., Sutherland.J. Curve stripping and nonlinear fitting of polyexponential functions to data using a microcomputer. Comput. Phys. 1988, 2:64-68.
14. Lam A.S.K., et al. In vitro and in vivo studies with pentavalent technecium-99m dimercaptosuccinic acid. Eur. J. Nucl. Med. 1996, 23:1575-1582.
15. Meikle S.R., et al. Small animal SPECT and its place in the matrix of molecular imaging technologies. Phys. Med. Biol. 2005, 50:R45-R61.
16. 99mTc-Sestamibi for palpable breast lesions. J. Nucl. Med. 2002, 43:882-888.
17. O'Connor M., et al. Molecular breast imaging. Expert Rev. Anticancer Ther. 2009, 9:1073-1080.
18. 99mTc-(V)DMSA scintimammography. Am. J. Clin. Oncol. 2007, 30:420-427.
19. Rottenberg S., et al. Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer. Proc. Natl. Acad. Sci. USA 2007, 104:12117-12122.
20. Watermann D.O., et al. Ultrasound morphology of invasive lobular breast cancer is different compared with other types of cancer. Ultrasound Med. Biol. 2005, 31:549-559.
21. Weissleder R. Scaling down imaging: molecular mapping of cancer in mice. Nat. Rev. Cancer 2002, 2:1-8.
22. 99mTc(III)DMSA. Nucl. Med. Biol. 1995, 22:689-691.
23. Yang J.G., et al. Primary osteagenic sarcoma of breast detected on Tc-99m MIBI scintigraphy and Tc-99m MDP skeletal scintigraphy. Ann. Nucl. Med. 2008, 22:79-82.
24. van Leeuwen F.W.B., et al. Noninvasive functional imaging of P-glycoprotein-mediated doxorubicin resistance in a mouse model of hereditary breast cancer to predict response, and assign P-gp inhibitor sensitivity. Eur. J. Nucl. Med. Mol. Imaging 2009, 36:406-412.